发明名称 |
Enzyme-catalyzed synthesis of site-specific and stoichiometric biomolecule-polymer conjugates |
摘要 |
Methods for producing polypeptide-polymer conjugates include attachment of an initiator agent to a polypeptide specifically at the C-terminus of the polypeptide using a sortase enzyme and in situ polymerization of a polymer from the C-terminus. The polypeptide-polymer conjugates may have desirable pharmacological properties and may be used therapeutically. |
申请公布号 |
US9592303(B2) |
申请公布日期 |
2017.03.14 |
申请号 |
US201414894731 |
申请日期 |
2014.05.30 |
申请人 |
Duke University |
发明人 |
Chilkoti Ashutosh;Qi Yizhi |
分类号 |
A61K47/48;C07K1/107;C08F122/10 |
主分类号 |
A61K47/48 |
代理机构 |
Michael Best & Friedrich LLP |
代理人 |
Michael Best & Friedrich LLP |
主权项 |
1. A method of making polypeptide-polymer conjugates having one or more altered pharmacological properties from a plurality of polypeptides having C-termini, the method comprising:
a) contacting the plurality of polypeptides with a sortase and an initiator agent under conditions that permit attachment of the initiator agent to the C-terminus to form a plurality of macroinitiators; and b) incubating the plurality of macroinitiators with a monomer under conditions that permit free-radical polymerization to occur from the initiator agent to form polypeptide-polymer conjugates, such that at least about 25% of the polypeptides have a conjugated polymer initiated solely from the C-terminus, wherein the polypeptide-polymer conjugates have an altered pharmacological property selected from at least one of (i) an in vivo half-life that is at least 25% greater compared with the in vivo half-life of the plurality of polypeptides; and (ii) an in vivo biodistribution to a tissue, organ or disease site that is at least 25% greater than the in vivo biodistribution of the plurality of polypeptides. |
地址 |
Durham NC US |